U.S., May 21 -- ClinicalTrials.gov registry received information related to the study (NCT07598890) titled 'Phase I Clinical Trial of Adsorbed Tetanus Vaccine' on May 11.
Brief Summary: This is a randomized, double-blind, parallel-controlled Phase I clinical trial of Adsorbed Tetanus Vaccine. Participants aged >=18 years will receive one dose of the vaccine to evaluate its safety and immunogenicity.
Study Start Date: May 21
Study Type: INTERVENTIONAL
Condition:
Tetanus Prevention
Intervention:
BIOLOGICAL: Tetanus Vaccine, Adsorbed
This investigational vaccine is manufactured by AIM Persistence Biopharmaceutical Co., Ltd. Participants will receive one dose of adsorbed tetanus vaccine via intramuscular injection into the deltoid muscl...